| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 16 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 16 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 16 |
| 3 | PREDNISONE | 14 |
| 4 | DOXORUBICIN | 12 |
| 5 | CILTACABTAGENE AUTOLEUCEL | 11 |
| 6 | BRENTUXIMAB VEDOTIN | 8 |
| 7 | ETOPOSIDE | 8 |
| 8 | METHOTREXATE | 6 |
| 9 | METHOTREXATE SODIUM | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 1 | 0.0029 |
| 1 | CILTACABTAGENE AUTOLEUCEL | 11 | 0.0017 |
| 2 | ROMIDEPSIN | 2 | 0.0012 |
| 3 | IDECABTAGENE VICLEUCEL | 1 | 0.0008 |
| 4 | BRENTUXIMAB VEDOTIN | 8 | 0.0008 |
| 5 | GLUTATHIONE | 1 | 0.0006 |
| 6 | VORINOSTAT | 1 | 0.0005 |
| 7 | EPIRUBICIN HYDROCHLORIDE | 2 | 0.0003 |
| 8 | CLADRIBINE | 3 | 0.0003 |
| 9 | BENDAMUSTINE HYDROCHLORIDE | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 21 |
| 1 | Alkylating Drug [EPC] | 19 |
| 2 | CD30-directed Immunoconjugate [EPC] | 8 |
| 3 | Topoisomerase Inhibitor [EPC] | 8 |
| 4 | Purine Antimetabolite [EPC] | 7 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 6 |
| 6 | Loop Diuretic [EPC] | 5 |
| 7 | Factor Xa Inhibitor [EPC] | 4 |
| 8 | Aldosterone Antagonist [EPC] | 3 |
| 9 | Aminosalicylate [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 8 | 0.0008 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 2 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 3 | Parenteral Iron Replacement [EPC] | 2 | 0.0001 |
| 4 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 5 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 6 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 19 | 0.0001 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 9 | Purine Antimetabolite [EPC] | 7 | 0.0001 |